Dr. Marco Emgenbroich studied chemistry at the Heinrich-Heine University of Düsseldorf, Germany. He then joined a graduate school program for PhD candidates on molecular physiology and in early 2003 received his doctorate degree in organic and macromolecular chemistry. After a postdoctoral fellowship in the bioanalytical applications of polymer matrices, Marco started his industrial career in drug delivery in a biotech company, where he worked on parenteral delivery and half-life extension of peptides and protein drugs. Early in 2011 he joined the R&D department of LTS Lohmann Therapy Systems in Germany, where he was responsible for the late-stage development program and global launch of the Neupro patch. Since 2015, Marco has been leading the pharmaceutical development department working on external projects in the area of transdermal patches and oral thin films.